Advanced cell culture system for disease research and drug development, including Organ-Chips, hardware, and software applications.| Emulate
By Jim Corbett, CEO, Emulate Drug discovery is at a crossroads. With nearly 90% of clinical trial candidates failing to reach FDA approval, the need for more predictive, human-relevant models […]| Emulate
Next-generation Organ-on-a-Chip technology allows researchers to emulate biology and predict human response. Get started today.| Emulate
Discover how FDA, NIH and Congress are fast tracking alternatives to animal testing—and how Organ on a Chip technology is reshaping drug development.| Emulate
This blog explores the landscape of NAMs, explains how they can be used synergistically, and highlights the key factors driving their recent momentum.| Emulate
In this blog, we’re recapping the exciting highlights from the 4th annual MPS World Summit conference that took place in Brussels, Belgium from June 9-13. Read on to catch up […] The post Expanding the Frontiers of Human Biology with Organ-on-a-Chip Technology: Highlights from the 2025 MPS World Summit appeared first on Emulate.| Emulate
Read about the fascinating history of cell culture, the advantages and disadvantages of both in vitro and in vivo research, and how cutting-edge Organ-on-a-Chip technology is bridging the gap the between the two.| Emulate
To benefit drug developers, models must have good specificity—that is, they must not misidentify good drugs as toxic. Read to learn more.| Emulate
Learn how complex in vitro models are allowing drug developers to tackle challenging diseases for the first time| Emulate
Explore commercially available Organ-Chip models of the human intestine, liver, kidney, and more.| Emulate
2024 was filled with groundbreaking discoveries that showcase the transformative potential of Organ-on-a-Chip technology.| Emulate
Drug-induced liver injury (DILI) remains a persistent challenge in drug development, endangering patient safety and delaying the availability of critical therapies. Just days ago, the FDA issued a warning about […] The post Ocaliva, Azelaprag, and the Continuing Challenge of Drug-Induced Liver Injury: A Call for Human-Relevant Models appeared first on Emulate.| Emulate
Organ-on-a-Chip technology continues to mature and gain adoption by the scientific community as a revolutionary tool for creating novel models of human-centric biology. In this ChipChat blog, we spoke with […] The post ChipChat: What is a “Big Toe-on-a-Chip”? Exploring the Endless Possibilities of Organ-Chips with Emulate Chief Scientific Officer Lorna Ewart, PhD appeared first on Emulate.| Emulate
Recently, we announced that the Emulate Liver-Chip S1 was accepted into the FDA’s ISTAND pilot program. To learn more, we sat down with Dr. Lorna Ewart, Chief Scientific Officer at […] The post Emulate Liver-Chip S1 Accepted into FDA’s ISTAND Pilot Program. What’s Next? appeared first on Emulate.| Emulate
From July 3rd–5th, 2024, Emulate joined the European Organ-on-Chip society (EUROoCS) annual conference hosted at the historical Leonardo Campus of Politecnico di Milano in the splendid city of Milan, Italy. […]| Emulate
Learn what microphysiological systems are and how they allow scientists to gain more human-relevant insights compared to conventional models.| Emulate
Learn about Organ-on-a-Chip technology and why it's setting the stage for the next generation of drug development and research.| Emulate
Read why research may need to end its reliance on NHPs, the gold standard for lab animals, and adopt advanced in vitro models.| Emulate